L-Methylfolate For Bipolar I depressive episodes: An open trial proof-of-concept registry

Journal of Affective Disorders

Volumn 207, Issue , 2017, Pages 429-433

  Nierenberg, Andrew A ^a,b   Montana, Rebecca ^a   Kinrys, Gustavo ^a,b   Deckersbach, Thilo ^a,b   Dufour, Steven ^a   Baek, Ji Hyun ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Samsung Medical Center   (South Korea)

Author keywords

Bipolar disorder; Deplin; Depression; L methylfolate

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CITALOPRAM; DESIPRAMINE; DEXAMPHETAMINE; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FOLIC ACID DERIVATIVE; LAMOTRIGINE; LEVO METHYLFOLATE; LITHIUM; LURASIDONE; METHYLPHENIDATE; MOOD STABILIZER; NEFAZODONE; PAROXETINE; PHENELZINE; QUETIAPINE; RISPERIDONE; SELEGILINE; SERTRALINE; TRANYLCYPROMINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROATE SEMISODIUM; VALPROIC ACID; VENLAFAXINE; 5-METHYLTETRAHYDROFOLATE; NEUROLEPTIC AGENT; TETRAHYDROFOLIC ACID DERIVATIVE;

ABDOMINAL DISCOMFORT; ABNORMAL SENSATION; ADULT; APATHY; ARTICLE; BIPOLAR I DISORDER; BLURRED VISION; CLINICAL ARTICLE; CONSTIPATION; DECREASED APPETITE; DEPRESSION; DIARRHEA; DISEASE REGISTRY; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSURIA; EFFECT SIZE; EMOTIONAL DISORDER; FAINTNESS; FATIGUE; FEMALE; HAIR LOSS; HALLUCINATION; HOT FLUSH; HUMAN; HYPERHIDROSIS; HYPERSALIVATION; HYPERVENTILATION; INCREASED APPETITE; MAJOR DEPRESSION; MALE; MENSTRUAL IRREGULARITY; MENTAL DETERIORATION; MENTAL PATIENT; MICTURITION DISORDER; MIDDLE AGED; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MUSCLE CRAMP; MUSCLE RIGIDITY; NAUSEA; NIGHTMARE; OPEN STUDY; ORGASM DISORDER; PARESTHESIA; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REMISSION; SCORING SYSTEM; SEXUAL AROUSAL DISORDER; SEXUAL DYSFUNCTION; SKIN BRUISING; SKIN TINGLING; SLEEP DISORDER; SLURRED SPEECH; SOMNOLENCE; STOMACH DISCOMFORT; SWELLING; TASTE DISORDER; THORAX PAIN; TREATMENT DURATION; TREATMENT OUTCOME; TREMOR; UNSTEADINESS; VOMITING; WEAKNESS; WEIGHT GAIN; WEIGHT REDUCTION; XEROSTOMIA; YOUNG MANIA RATING SCALE; BIPOLAR DISORDER; CLINICAL TRIAL; DEPRESSIVE DISORDER, MAJOR; REGISTER;

ADULT; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; REGISTRIES; TETRAHYDROFOLATES; TREATMENT OUTCOME;

EID: 84993141503     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2016.09.053     Document Type: Article

References (37)

1. Akoglu, B., Schrott, M., Bolouri, H., Jaffari, A., Kutschera, E., Caspary, W., Faust, D., The folic acid metabolite L-5-methyltetrahydrofolate effectively reduces total serum homocysteine level in orthotopic liver transplant recipients: a double-blind placebo-controlled study. Eur. J. Clin. Nutr. 62 (2008), 796–801.
2. Altshuler, L.L., Gitlin, M.J., Mintz, J., Leight, K.L., Frye, M.A., Subsyndromal depression is associated with functional impairment in patients with bipolar disorder. J. Clin. Psychiatry 63 (2002), 807–811.
3. Endicott, J., Nee, J., Harrison, W., Blumenthal, R., Quality of life enjoyment and satisfaction questionnaire. Psychopharmacol. Bull. 29 (1993), 321–326.
4. Farah, A., The role of L-methylfolate in depressive disorders. CNS Spectr. 14 (2009), 2–7.
5. Fava, M., Iosifescu, D.V., Pedrelli, P., Baer, L., Reliability and validity of the Massachusetts general hospital cognitive and physical functioning questionnaire. Psychother. Psychosom. 78 (2009), 91–97.
6. Geddes, J.R., Gardiner, A., Rendell, J., Voysey, M., Tunbridge, E., Hinds, C., Yu, L.-M., Hainsworth, J., Attenburrow, M.-J., Simon, J., Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2×2 factorial randomised trial. Lancet Psychiatry 3 (2016), 31–39.
7. Ginsberg, L.D., Oubre, A.Y., Daoud, Y.A., L-methylfolate Plus SSRI or SNRI from Treatment Initiation Compared to SSRI or SNRI Monotherapy in a Major Depressive Episode. Innov. Clin. Neurosci. 8 (2011), 19–28.
8. Godfrey, P., Toone, B., Bottiglien, T., Laundy, M., Reynolds, E., Carney, M., Flynn, T., Chanarin, I., Enhancement of recovery from psychiatric illness by methylfolate. Lancet 336 (1990), 392–395.
9. Greenhouse, S.W., Geisser, S., On methods in the analysis of profile data. Psychometrika 24 (1959), 95–112.
10. Guaraldi, G.P., Fava, M., Mazzi, F., la Greca, P., An open trial of methyltetrahydrofolate in elderly depressed patients. Ann. Clin. Psychiatry 5 (1993), 101–105.
11. Joffe, R.T., MacQueen, G.M., Marriott, M., Trevor Young, L., A prospective, longitudinal study of percentage of time spent ill in patients with bipolar I or bipolar II disorders. Bipolar Disord. 6 (2004), 62–66.
12. Judd, L.L., Akiskal, H.S., The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J. Affect. Disord. 73 (2003), 123–131.
13. Judd, L.L., Akiskal, H.S., Schettler, P.J., Endicott, J., Maser, J., Solomon, D.A., Leon, A.C., Rice, J.A., Keller, M.B., The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch. Gen. Psychiatry 59 (2002), 530–537.
14. Karabiber, H., Sonmezgoz, E., Ozerol, E., Yakinci, C., Otlu, B., Yologlu, S., Effects of valproate and carbamazepine on serum levels of homocysteine, vitamin B12, and folic acid. Brain Dev. 25 (2003), 113–115.
15. Khalife, S., Singh, V., Muzina, D.J., Definition and etiology. Bipolar Disord., 2010.
16. Kogan, J.N., Otto, M.W., Bauer, M.S., Dennehy, E.B., Miklowitz, D.J., Zhang, H.W., Ketter, T., Rudorfer, M.V., Wisniewski, S.R., Thase, M.E., Demographic and diagtic characteristics of the first 1000 patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Bipolar Disord. 6 (2004), 460–469.
17. Lecrubier, Y., Sheehan, D., Weiller, E., Amorim, P., Bonora, I., Sheehan, K.H., Janavs, J., Dunbar, G., The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. Eur. Psychiatry 12 (1997), 224–231.
18. Leon, A., Solomon, D., Mueller, T., Turvey, C., Endicott, J., Keller, M., The Range of Impaired Functioning Tool (LIFE–RIFT): a brief measure of functional impairment. Psychol. Med. 29 (1999), 869–878.
19. Levine, J., Schooler, N.R., SAFTEE: a technique for the systematic assessment of side effects in clinical trials. Psychopharmacol. Bull. 22 (1986), 343–381.
20. Montgomery, S.M., Depressive symptoms in acute schizophrenia. Prog. Neuro-Psychopharmacol. 3 (1979), 429–433.
21. Nierenberg, A.A., A critical appraisal of treatments for bipolar disorder. Prim. Care Companion J. Clin. Psychiatry 12 (2010), 23–29.
22. Nierenberg, A.A., Friedman, E.S., Bowden, C.L., Sylvia, L.G., Thase, M.E., Ketter, T., Ostacher, M.J., Leon, A.C., Reilly-Harrington, N., Iosifescu, D.V., Pencina, M., Severe, J.B., Calabrese, J.R., Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium. Am. J. Psychiatry 170 (2013), 102–110.
23. Nierenberg, A.A., Sylvia, L.G., Leon, A.C., Reilly-Harrington, N.A., Shesler, L.W., McElroy, S.L., Friedman, E.S., Thase, M.E., Shelton, R.C., Bowden, C.L., Tohen, M., Singh, V., Deckersbach, T., Ketter, T.A., Kocsis, J.H., McInnis, M.G., Schoenfeld, D., Bobo, W.V., Calabrese, J.R., Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): a pragmatic trial of complex treatment for a complex disorder. Clin. Trials 11 (2014), 114–127.
24. Pacchiarotti, I., Bond, D.J., Baldessarini, R.J., Nolen, W.A., Grunze, H., Licht, R.W., Post, R.M., Berk, M., Goodwin, G.M., Sachs, G.S., Tondo, L., Findling, R.L., Youngstrom, E.A., Tohen, M., Undurraga, J., Gonzalez-Pinto, A., Goldberg, J.F., Yildiz, A., Altshuler, L.L., Calabrese, J.R., Mitchell, P.B., Thase, M.E., Koukopoulos, A., Colom, F., Frye, M.A., Malhi, G.S., Fountoulakis, K.N., Vazquez, G., Perlis, R.H., Ketter, T.A., Cassidy, F., Akiskal, H., Azorin, J.M., Valenti, M., Mazzei, D.H., Lafer, B., Kato, T., Mazzarini, L., Martinez-Aran, A., Parker, G., Souery, D., Ozerdem, A., McElroy, S.L., Girardi, P., Bauer, M., Yatham, L.N., Zarate, C.A., Nierenberg, A.A., Birmaher, B., Kanba, S., El-Mallakh, R.S., Serretti, A., Rihmer, Z., Young, A.H., Kotzalidis, G.D., MacQueen, G.M., Bowden, C.L., Ghaemi, S.N., Lopez-Jaramillo, C., Rybakowski, J., Ha, K., Perugi, G., Kasper, S., Amsterdam, J.D., Hirschfeld, R.M., Kapczinski, F., Vieta, E., The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am. J. Psychiatry 170 (2013), 1249–1262.
25. Papakostas, G.I., Shelton, R.C., Zajecka, J.M., Etemad, B., Rickels, K., Clain, A., Baer, L., Dalton, E.D., Sacco, G.R., Schoenfeld, D., L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials. Am. J. Psychiatry 169 (2012), 1267–1274.
26. Passeri, M., Cucinotta, D., Abate, G., Senin, U., Ventura, A., Stramba Badiale, M., Diana, R., La Greca, P., Le Grazie, C., Oral 5′-methyltetrahydrofolic acid in senile organic mental disorders with depression: results of a double-blind multicenter study. Aging (Milano) 5 (1993), 63–71.
27. Post, R.M., Denicoff, K.D., Leverich, G.S., Altshuler, L.L., Frye, M.A., Suppes, T.M., Rush, A.J., Keck, P.E. Jr, McElroy, S.L., Luckenbaugh, D.A., Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. J. Clin. Psychiatry 64 (2003), 680–690.
28. Rush, A.J., Trivedi, M.H., Ibrahim, H.M., Carmody, T.J., Arnow, B., Klein, D.N., Markowitz, J.C., Ninan, P.T., Kornstein, S., Manber, R., The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol. Psychiatry 54 (2003), 573–583.
29. Scott, J., Weir, D., The methyl folate trap: a physiological response in man to prevent methyl group deficiency in kwashiorkor (methionine deficiency) and an explanation for folic-acid-induced exacerbation of subacute combined degeneration in pernicious anaemia. Lancet 318 (1981), 337–340.
30. Spearing, M.K., Post, R.M., Leverich, G.S., Brandt, D., Nolen, W., Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res. 73 (1997), 159–171.
31. Stahl, S.M., Novel therapeutics for depression: L-methylfolate as a trimonoamine modulator and antidepressant-augmenting agent. CNS Spectr. 12 (2007), 739–744.
32. Tamura, T., Aiso, K., Johnston, K.E., Black, L., Faught, E., Homocysteine, folate, vitamin B-12 and vitamin B-6 in patients receiving antiepileptic drug monotherapy. Epilepsy Res. 40 (2000), 7–15.
33. Trivedi, M.H., Wisniewski, S.R., Morris, D.W., Fava, M., Gollan, J.K., Warden, D., Nierenberg, A.A., Gaynes, B.N., Husain, M.M., Luther, J.F., Concise Health Risk Tracking scale: a brief self-report and clinician rating of suicidal risk. J. Clin. Psychiatry 72 (2011), 757–764.
34. Úbeda, N., Alonso-Aperte, E., Varela-Moreiras, G., Acute valproate administration impairs methionine metabolism in rats. J. Nutr. 132 (2002), 2737–2742.
35. Verrotti, A., Pascarella, R., Trotta, D., Giuva, T., Morgese, G., Chiarelli, F., Hyperhomocysteinemia in children treated with sodium valproate and carbamazepine. Epilepsy Res. 41 (2000), 253–257.
36. Willems, F.F., Boers, G.H., Blom, H.J., Aengevaeren, W.R., Verheugt, F.W., Pharmacokinetic study on the utilisation of 5–methyltetrahydrofolate and folic acid in patients with coronary artery disease. Br. J. Pharmacol. 141 (2004), 825–830.
37. Young, R., Biggs, J., Ziegler, V., Meyer, D., A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 133 (1978), 429–435.